Skip to main content

Articles

Page 7 of 31

  1. Over the past decade in the USA, increases in overdose rates of cocaine and psychostimulants with opioids were highest among Black, compared to White, populations. Whether fentanyl has contributed to the rise ...

    Authors: Angela T. Estadt, Brian N. White, JaNelle M. Ricks, Kathryn E. Lancaster, Staci Hepler, William C. Miller and David Kline
    Citation: Harm Reduction Journal 2024 21:13
    Content type: Research Published on:

  2. The first Harm Reduction DACH Conference [DACH = D (Germany), A (Austria), CH (Switzerland)] took place in Vienna on June 23rd, 2023, and focused on tobacco harm reduction. It is the first conference bringing ...

    Authors: Larissa Steimle, Simon Fleißner, Hans Haltmayer, Thilo Beck, Alfred Springer and Heino Stöver
    Citation: Harm Reduction Journal 2024 21:12
    Content type: Meeting Report Published on:

  3. Shifts in the US drug supply, including the proliferation of synthetic opioids and emergence of xylazine, have contributed to the worsening toll of the overdose epidemic. Drug checking services offer a critica...

    Authors: Kyle J. Moon, Heather D. Whitehead, Anne Trinh, Kathryn A. Hasenstab, Kathleen L. Hayes, Debra Stanley, Brittany Carter, Rick Barclay, Marya Lieberman and Saira Nawaz
    Citation: Harm Reduction Journal 2024 21:11
    Content type: Perspective Published on:

  4. While women living with HIV (WLWH) are twice as likely to report severe or undertreated chronic pain compared to men, little is known about pain among WLWH. Our goal was to characterize the correlates of pain ...

    Authors: Sophia Ly, Kate Shannon, Melissa Braschel, Haoxuan Zhou, Andrea Krüsi and Kathleen Deering
    Citation: Harm Reduction Journal 2024 21:10
    Content type: Research Published on:

  5. Each year, thousands of migrants enter the EU. Data on drug use in migrant populations are scarce and inconclusive. However, several risk factors make them particularly vulnerable to engaging in problematic dr...

    Authors: Lena van Selm, Trenton M. White, Camila A. Picchio, Ana Requena-Méndez, Machteld Busz, Roberto Perez Gayo, Aline Pouille, Pedro Mateu Gelabert and Jeffrey V. Lazarus
    Citation: Harm Reduction Journal 2024 21:9
    Content type: Perspective Published on:

  7. Programmatic and financial sustainability of health responses dependent on donor funding has risen as a major concern. In the HIV field in particular, it generated a number of instruments and assessments on su...

    Authors: Raminta Stuikyte, Ivan Varentsov, Catherine Cook and Sergii Dvoriak
    Citation: Harm Reduction Journal 2024 21:7
    Content type: Methodology Published on:

    The Correction to this article has been published in Harm Reduction Journal 2024 21:27

  8. Globally, People Who Inject Drugs (PWID) have limited healthcare, treatment, and prevention services, and they frequently experience stigma and negative attitudes toward healthcare providers when accessing ser...

    Authors: Cynthia Semá Baltazar, Auria Ribeiro Banze, Jessica Seleme and Makini Boothe
    Citation: Harm Reduction Journal 2024 21:6
    Content type: Comment Published on:

  9. With growing rates of unregulated drug toxicity death and concerns regarding COVID-19 transmission among people who use drugs, in March 2020, prescribed safer supply guidance was released in British Columbia. ...

    Authors: Heather Palis, Beth Haywood, Jenny McDougall, Chloé G. Xavier, Roshni Desai, Samuel Tobias, Heather Burgess, Max Ferguson, Lisa Liu, Brooke Kinniburgh, Amanda K. Slaunwhite, Alexis Crabtree and Jane A. Buxton
    Citation: Harm Reduction Journal 2024 21:5
    Content type: Research Published on:

  10. HIV self-testing (HIVST) could increase HIV testing access among people who inject drugs (PWID), and secondary distribution (i.e., peer-delivery) of HIVST kits in PWID social networks could further expand cove...

    Authors: Heather A. Pines, William H. Eger, Britt Skaathun, Carlos F. Vera, Alicia Harvey-Vera, Gudelia Rangel, Steffanie A. Strathdee and Angela R. Bazzi
    Citation: Harm Reduction Journal 2024 21:4
    Content type: Research Published on:

  12. Women with substance-use issues are overrepresented in prison. Research on women’s recidivism often focuses on offending behaviour rather than the health and social circumstances women are experiencing when re...

    Authors: Layla Maree Edwards, Sungwon Chang, Reem Zeki, Sacha Kendall Jamieson, Julia Bowman, Craig Cooper and Elizabeth Sullivan
    Citation: Harm Reduction Journal 2024 21:2
    Content type: Research Published on:

  13. Medical cannabis use and public acceptance in the United States have increased over the past 25 years. However, access to medical cannabis remains limited, particularly for underserved populations. To understa...

    Authors: Eloise W. Freitag, Yuval Zolotov, Jayabhargav Annam, Jaqueline Labins, Jaclyn M. Yamada, Syeda Masharab Jillani, Julia H. Arnsten and Deepika E. Slawek
    Citation: Harm Reduction Journal 2024 21:1
    Content type: Brief Report Published on:

  14. Medications for opioid use disorder (OUD) are effective at preventing overdose and infectious disease but are vastly under-prescribed in the US. For decades, prescribers faced additional training and regulatio...

    Authors: Berkeley Franz, Lindsay Y. Dhanani, O. Trent Hall, Daniel L. Brook, Janet E. Simon and William C. Miller
    Citation: Harm Reduction Journal 2023 20:180
    Content type: Research Published on:

  16. Lives lost in North America due to the unregulated drug poisoning emergency are preventable and those who survive an opioid overdose may suffer long-term disability. Rates of opioid overdose more than doubled ...

    Authors: Max Ferguson, Paul Choisil, Jessica Lamb, Charlene Burmeister, Cheri Newman, Kurt Lock, Samuel Tobias, Lisa Liu and Jane A. Buxton
    Citation: Harm Reduction Journal 2023 20:178
    Content type: Research Published on:

  17. Harm reduction strategies can decrease morbidity and mortality associated with substance use. Various barriers limit conversation around substance use between clinicians and patients. Graphic medicine techniqu...

    Authors: Leah H. Harvey, Westyn Branch-Elliman, Jacqueline Boudreau, Samantha K. Sliwinski, Allen L. Gifford, Minh Q. Ho, Elizabeth Dinges and Justeen Hyde
    Citation: Harm Reduction Journal 2023 20:177
    Content type: Research Published on:

  18. Rave music parties (RMP) are a world-wide socio-cultural phenomenon, where people listen to rave music while frequently consuming psychedelic drugs. Epidemiological studies have emphasized the hazardous conseq...

    Authors: Yula Milshteyn and Moshe Bensimon
    Citation: Harm Reduction Journal 2023 20:176
    Content type: Research Published on:

  19. Fentanyl test strips (FTS) are a commonly deployed tool in drug checking, used to test for the presence of fentanyl in street drug samples prior to consumption. Previous reports indicate that in addition to fe...

    Authors: Kathleen L. Hayes and Marya Lieberman
    Citation: Harm Reduction Journal 2023 20:175
    Content type: Research Published on:

  20. Perception of drug adulteration has increased in Mexico, but there is little research on adulterants and toxicity. The aim of this study was to identify drug composition in an electronic music outdoor festival...

    Authors: Silvia L. Cruz, Miguel Bencomo-Cruz, María E. Medina-Mora, Fabiola Vázquez-Quiroz and Clara Fleiz-Bautista
    Citation: Harm Reduction Journal 2023 20:174
    Content type: Research Published on:

  21. BUP-XR (SUBLOCADE®) is the first buprenorphine extended-release subcutaneous injection approved in the USA for monthly treatment of moderate-to-severe opioid use disorder (OUD). Among patients with OUD, those who...

    Authors: Mark K. Greenwald, Katharina L. Wiest, Barbara R. Haight, Celine M. Laffont and Yue Zhao
    Citation: Harm Reduction Journal 2023 20:173
    Content type: Research Published on:

  22. This paper applies the theory of change model (Kotter in Harv Bus Rev 2:59–67, 1995; Moore et al. in Viet Nam J Public Health 1(1):66–75, 2013) to describe the pathway that lead to Australia’s first pill testi...

    Authors: David Caldicott, Toni Makkai, Malcolm McLeod, Stephanie Tzanetis and Gino Vumbaca
    Citation: Harm Reduction Journal 2023 20:172
    Content type: Case Study Published on:

  23. Bystander administration of naloxone is a critical strategy to mitigate opioid overdose mortality. To ensure bystanders’ willingness to carry and administer naloxone in response to a suspected overdose, it is ...

    Authors: Katherine R. Marks, Douglas R. Oyler, Justin C. Strickland, Jody Jaggers, Monica F. Roberts, Dustin K. Miracle, Chase Barnes, Feitong Lei, Amanda Smith, Eric Mackin, Martika C. Martin and Patricia R. Freeman
    Citation: Harm Reduction Journal 2023 20:171
    Content type: Research Published on:

  25. The Canadian drug supply has significantly increased in toxicity over the past few years, resulting in the worsening of the overdose crisis. A key initiative implemented during this crisis has been data monito...

    Authors: Melissa Perri, Triti Khorasheh, David Edward-Ooi Poon, Nat Kaminski, Sean LeBlanc, Leticia Mizon, Ashley Smoke, Carol Strike and Pamela Leece
    Citation: Harm Reduction Journal 2023 20:169
    Content type: Research Published on:

  26. The experiences and perceived support needs of harm reduction workers in the USA have been understudied. While previous research has explored staff burnout and role-related stress, there is a research gap arou...

    Authors: Katherine Hill, Katherine Dunham, Lauretta E. Grau and Robert Heimer
    Citation: Harm Reduction Journal 2023 20:168
    Content type: Research Published on:

  27. Interpersonal violence and opioid use disorder are significant and intersecting public health concerns in the USA. The current study evaluated the consequences associated with opioid use (e.g., physical, socia...

    Authors: Prachi H. Bhuptani, Lindsay M. Orchowski, Shannon R. Forkus, Noam G. Newberger and Nicole H. Weiss
    Citation: Harm Reduction Journal 2023 20:167
    Content type: Brief Report Published on:

  28. Overdoses have surged in rural areas in the U.S. and globally for years, but harm reduction interventions have lagged. Overdose education and naloxone distribution (OEND) programs reduce overdose mortality, bu...

    Authors: Zora Kesich, Umedjon Ibragimov, Kelli Komro, Kenneth Lane, Melvin Livingston, April Young and Hannah L. F. Cooper
    Citation: Harm Reduction Journal 2023 20:166
    Content type: Research Published on:

  29. Women who inject drugs in Ukraine are disproportionately burdened by HIV. To help address the needs of this population, a greater understanding of how interventions may uniquely benefit women who inject drugs ...

    Authors: John Mark Wiginton, Robert Booth, Laramie R. Smith, Sajina Shakya, Cristina Espinosa da Silva, Thomas L. Patterson and Eileen V. Pitpitan
    Citation: Harm Reduction Journal 2023 20:165
    Content type: Research Published on:

  30. In Kenya, violence is common among people who inject drugs (PWID) living with HIV and their sexual and injecting partners and may lead to decreased uptake of HIV services, increased HIV risk behaviors, and inc...

    Authors: Sai Win Kyaw Htet Aung, Hanley Kingston, Loice W. Mbogo, Betsy Sambai, Aliza Monroe-Wise, Natasha T. Ludwig-Barron, David Bukusi, William Sinkele, Esther Gitau, Sarah Masyuko, Joshua T. Herbeck, Carey Farquhar and Brandon L. Guthrie
    Citation: Harm Reduction Journal 2023 20:164
    Content type: Research Published on:

  31. The rising rates of drug use-related complications call for a paradigm shift in the care for people who use drugs. While addiction treatment and harm reduction have historically been siloed in the US, co-locat...

    Authors: Margaret Shang, Brent Thiel, Jane M. Liebschutz, Kevin L. Kraemer, Ariana Freund and Raagini Jawa
    Citation: Harm Reduction Journal 2023 20:163
    Content type: Comment Published on:

  32. Injectable opioid agonist treatment (iOAT) is an effective option to support people living with opioid use disorder (OUD) who have not sufficiently benefitted from oral OAT. However, iOAT has been criticised b...

    Authors: Zoe Friedmann, Hans-Tilmann Kinkel, Claudia Kühner, Andreas Zsolnai, Inge Mick and Annette Binder
    Citation: Harm Reduction Journal 2023 20:162
    Content type: Research Published on:

  33. The methodological part of the large-scale study on the psychosocial distress of young people in Slovenia focused on vulnerable young people who use drugs and explored the potential of online interventions in ...

    Authors: Matej Sande, Bojan Dekleva, Špela Razpotnik, Darja Tadič, Mija Marija Klemenčič Rozman and Jana Rapuš Pavel
    Citation: Harm Reduction Journal 2023 20:161
    Content type: Research Published on:

  34. Providing sterile drug smoking materials to people who use drugs can prevent the acquisition of infectious diseases and reduce overdose risk. However, there is a lack of understanding of how these practices ar...

    Authors: Abigail Tapper, Catherine Ahern, Zoe Graveline-Long, Noam G. Newberger and Jaclyn M. W. Hughto
    Citation: Harm Reduction Journal 2023 20:160
    Content type: Review Published on:

  35. Opioid overdose deaths are of great concern to public health, with over one million lives lost since 1999. While many efforts have been made to mitigate these, Black communities continue to experience a greate...

    Authors: Dong-Chul Seo, Naomi Satterfield, Leonardo Alba-Lopez, Shin Hyung Lee, Charlotte Crabtree and Nicki Cochran
    Citation: Harm Reduction Journal 2023 20:159
    Content type: Research Published on:

  36. Opioid withdrawal is a regular occurrence among many people who use illicit opioids (PWUIO) that has also been shown to increase their willingness to engage in risk-involved behavior. The proliferation of fent...

    Authors: David Frank, Luther Elliott, Charles M. Cleland, Suzan M. Walters, Paul J. Joudrey, Danielle M. Russell, Beth E. Meyerson and Alex S. Bennett
    Citation: Harm Reduction Journal 2023 20:158
    Content type: Research Published on:

  37. Research conducted in urban areas has highlighted the impact of housing instability on people who inject drugs (PWID), revealing that it exacerbates vulnerability to drug-related harms and impedes syringe serv...

    Authors: April M. Ballard, Dylan Falk, Harris Greenwood, Paige Gugerty, Judith Feinberg, Peter D. Friedmann, Vivian F. Go, Wiley D. Jenkins, P. Todd Korthuis, William C. Miller, Mai T. Pho, David W. Seal, Gordon S. Smith, Thomas J. Stopka, Ryan P. Westergaard, William A. Zule…
    Citation: Harm Reduction Journal 2023 20:157
    Content type: Research Published on:

  38. British Columbia (BC) has been facing a public health emergency of overdose since 2016, with rural regions of the province facing the highest rates of death. Peers (in this case, people with lived experience o...

    Authors: Marnie Scow, Jenny McDougall, Amanda Slaunwhite and Heather Palis
    Citation: Harm Reduction Journal 2023 20:156
    Content type: Case Report Published on:

  40. The Deadly Liver Mob (DLM) program is a peer-led health promotion program that aims to improve access to screening and treatment for blood borne viruses and sexually transmissible infections for Aboriginal and...

    Authors: Elena Cama, Kim Beadman, Mitch Beadman, Melinda Walker and Carla Treloar
    Citation: Harm Reduction Journal 2023 20:154
    Content type: Research Published on:

    The Correction to this article has been published in Harm Reduction Journal 2024 21:32

  41. The Deadly Liver Mob (DLM) is a peer-delivered incentivised health promotion program by and for Aboriginal and Torres Strait Islander Australians, and was introduced in response to the disproportionate number ...

    Authors: Carla Treloar, Kim Beadman, Mitch Beadman, Kerri-Anne Smith, Jade Christian, Aunty Clair Jackson, Beverley Tyson, Clayton Anderson, Larissa Smyth, Melinda Walker, Jennifer Heslop, Gary Gahan, Victor Tawil, Felicity Sheaves, Louise Maher, Julie Page…
    Citation: Harm Reduction Journal 2023 20:153
    Content type: Comment Published on:

  42. We evaluated racial/ethnic differences in the receipt of naloxone distributed by opioid overdose prevention programs (OOPPs) in New York City (NYC).

    Authors: Shayla Nolen, Andrew J. Trinidad, Ashly E. Jordan, Traci C. Green, Ali Jalali, Sean M. Murphy, Xiao Zang, Brandon D. L. Marshall and Bruce R. Schackman
    Citation: Harm Reduction Journal 2023 20:152
    Content type: Brief Report Published on:

  43. With many drug-related deaths driven by potent synthetic opioids tainting the illicit drug supply, drug checking services are becoming a key harm reduction strategy. Many drug checking technologies are availab...

    Authors: Chloe Grace Rose, A. Simon Pickard, Victoria Kulbokas, Stacey Hoferka, Kaitlyn Friedman, Jennifer Epstein and Todd A. Lee
    Citation: Harm Reduction Journal 2023 20:151
    Content type: Research Published on:

  44. Recent policies have lessened restrictions around prescribing buprenorphine-naloxone (buprenorphine) for the treatment of opioid use disorder (OUD). The primary concern expressed by critics of these policies i...

    Authors: Joëlla W. Adams, Michael Duprey, Sazid Khan, Jessica Cance, Donald P. Rice and Georgiy Bobashev
    Citation: Harm Reduction Journal 2023 20:150
    Content type: Research Published on:

  45. Drug consumption rooms (DCRs) have been developed in cities with open drug scenes, with the aim to reduce drug-related harm. In Lyon, France's second-largest city, there is no distinct drug use area, which rai...

    Authors: Mathieu Chappuy, Philippe Lack, Baptiste David, Gilles Penavayre, Damien Thabourey, Maira Landulpho, Anthony Plasse, Christophe Icard, François Bailly, Faroudja Boutahra, Pierre Pradat, Marianne Maynard, Marie Jauffret-Roustide, Julia de Ternay and Benjamin Rolland
    Citation: Harm Reduction Journal 2023 20:149
    Content type: Brief Report Published on:

  46. Despite law enforcement and health interventions, open drug scenes have led to problems in many countries. The problems are, however, insufficiently explored. There are different types of drug scenes in Iran. ...

    Authors: Sahar Eshrati, MohammadBagher Saberizafarghandi, Meroe Vameghi, Reza Arezoomandan, Hadi Ranjbar, Thomas Clausen and Helge Waal
    Citation: Harm Reduction Journal 2023 20:148
    Content type: Research Published on:

  47. Flavored e-cigarettes remain a controversial topic with regulators planning or already implementing restrictions worldwide. In this study, we examined patterns of flavor use in e-cigarettes among a convenience...

    Authors: Konstantinos Farsalinos, Christopher Russell, Riccardo Polosa, Konstantinos Poulas, George Lagoumintzis and Anastasia Barbouni
    Citation: Harm Reduction Journal 2023 20:147
    Content type: Research Published on:

  48. Social work with people who use drugs (PWUD) has traditionally focused on abstinence and rehabilitation. In recent years, harm reduction has gained an increasingly more important role in social work with PWUD,...

    Authors: Torkel Richert, Anke Stallwitz and Johan Nordgren
    Citation: Harm Reduction Journal 2023 20:146
    Content type: Research Published on:

  49. Most people who inject drugs (PWID) in Iran have not undergone recent HIV testing. While PWID face barriers when seeking HIV testing at health facilities, HIV self-testing (HIVST) could be a promising approach...

    Authors: Mehrdad Khezri, Emily Goldmann, Fatemeh Tavakoli, Mohammad Karamouzian, Mostafa Shokoohi, Soheil Mehmandoost, Nima Ghalekhani, Ali Akbar Haghdoost, Don Des Jarlais, Ali Mirzazadeh and Hamid Sharifi
    Citation: Harm Reduction Journal 2023 20:145
    Content type: Research Published on:

  50. Over 109,000 people in the USA died from a drug overdose in 2022. More alarming is the amount of drug overdose deaths involving synthetic opioids other than methadone (SOOM), primarily fentanyl. From 2015 to 2...

    Authors: Shawkut Amaan Ali, Jasmine Shell, Raymond Harris and Marshall Bedder
    Citation: Harm Reduction Journal 2023 20:144
    Content type: Research Published on:
Submit manuscript
  • ISSN: 1477-7517 (electronic)

Harm Reduction Journal

ISSN: 1477-7517